Aker BioMarine
| Type | Public (OSE: AKBM) |
|---|---|
| Industry | Marine biotechnology |
| Headquarters | , |
| Key people | Matts Johansen (CEO) Ola Snøve (chair) |
| Revenue | 469 million kr (2012) |
| NOK –35 million (2012) | |
| NOK –66 million (2012) | |
Number of employees | 32 (2026) |
| Website | www |
Aker BioMarine is a norwegian company that develops krill-derived products for consumer health and nutrition.
It is the world's largest catcher of krill, with 64% of 620,000 metric tons of krill taken from the Southern Ocean in 2025. Given the resulting impact risk on the Antarctica ecosystem and whales, Aker BioMarine is the subject of critics, its ship Antarctic Sea being struck by Paul Watson's ship Bandero on March 31, 2026.